SecBot SecBot
8-K ·Filed Aug 5, 2026

LFCR

LIFECORE BIOMEDICAL, INC. \DE\
NEUTRAL
Impact 5/10
Horizondays Processed3mo ago SEC0001005286-26-000032
8-K Item 2.02: Earnings release
Actionable Insight • Neutral

LLM returned non-JSON response. Review the filing manually.

DirectionNeutral
Confidencelow
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$4.44
T+0 close · Aug 5, 2026 · via day close
Latest settled
+46.85%
T+60 · $6.52
Vs SPY
+46.90%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 5 $4.44entry
  2. T+1 · 3mo ago +9.01%α +9.17% · $4.84
  3. T+5 · 3mo ago +7.43%α +7.08% · $4.77
  4. T+20 · 3mo ago +6.76%α +7.36% · $4.74
  5. T+60 · 19d ago +46.85%α +46.90% · $6.52
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

{ "summary": "Lifecore Biomedical reported Q2 2026 revenue of $34.2M (down 6.2% YoY), a GAAP net loss of $6.2M ($0.19 per share vs consensus -$0.17), and Adjusted EBITDA of $8.6M (slightly below $9.1M prior year). Despite the revenue decline and wider net loss, the company reaffirmed its full-year 2026 guidance ($120-125M revenue, $20.5-25M Adjusted EBITDA) and highlighted strong pipeline growth with 13 new programs added over the past 12 months, including 8 late-stage. The combination of stab

Financial Impact

Unknown

Risk Factors

  • Analysis may be incomplete

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
73% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001005286-26-000032
Exhibit: ex992_lfcrpresentation.htm0001005286-26-000032
Document: lfcr-20260805.htm0001005286-26-000032
Document: 0001005286-26-000032-index-headers.html0001005286-26-000032
Document: 0001005286-26-000032-index.html0001005286-26-000032
Document: 0001005286-26-000032.txt0001005286-26-000032
8-K Data (Synthetic)0001005286-26-000032

Track record

20 reports on LFCR

Performance horizon

6 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +45.27% at T+60 after the Mar 26, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $6.42 Now $6.42 +0.08% settles Nov 18
  2. Nov 13, 20263d ago DEFM14A Neutral 6/10 Entry $6.42 Now $6.42 +0.00% settles Nov 17
  3. Nov 5, 202611d ago 8-K / DEFA14A Neutral 5/10 Entry $6.40 to $6.36 Now $6.42 +0.31% ▼ −0.63% −0.94% vs SPY
  4. Nov 4, 202612d ago 8-K Bearish 6/10 No price data
  5. Nov 4, 202612d ago Press Release Bearish 5/10 Entry $6.44 to $6.40 Now $6.42 +0.31% ▲ +0.62% −3.79% vs SPY
  6. Oct 30, 202617d ago PREM14A Neutral 5/10 Entry $6.39 to $6.42 Now $6.42 +0.47% ▲ +0.47% +0.17% vs SPY
  7. Oct 20, 202627d ago 8-K Neutral 3/10 Entry $6.37 to $6.37 Now $6.42 +0.78% · 0.00% +1.18% vs SPY
  8. Sep 28, 20267w ago SC 13D/A Bullish 7/10 Entry $6.59 to $6.58 Now $6.42 −2.58% ▼ −0.15% +0.05% vs SPY
  9. Sep 28, 20267w ago DEFA14A Bullish 7/10 Entry $6.52 to $6.59 Now $6.42 −1.53% ▲ +1.07% +1.26% vs SPY
  10. Sep 28, 20267w ago 8-K Bullish 8/10 Entry $6.52 to $6.59 Now $6.42 −1.53% ▲ +1.07% +1.26% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 7h 33m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 5, 2026